Thomas Cerny
Präsident bei Swiss Cancer League
Profil
Thomas Cerny is currently a Director at ProteoMediX AG and TOLREMO therapeutics AG, and the President of Swiss Cancer League.
He was previously a Director at THERAMetrics holding AG from 2009 to 2011.
Prior to his current positions, he was the Head-Oncology at the University of St. Gallen starting in 2009.
He holds a doctorate degree from the University of Bern.
Aktive Positionen von Thomas Cerny
| Unternehmen | Position | Beginn |
|---|---|---|
| University of St. Gallen | Corporate Officer/Principal | 21.06.2010 |
| Swiss Cancer League | Präsident | 12.01.2011 |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | - |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Cerny
| Unternehmen | Position | Ende |
|---|---|---|
THERAMetrics holding AG
 THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Direktor/Vorstandsmitglied | 26.05.2011 |
Ausbildung von Thomas Cerny
| University of Bern | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
THERAMetrics holding AG
THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Health Technology |
| Swiss Cancer League | |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Commercial Services |
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
